当前位置: 首页 > 详情页

The contralateral co-movement test in a Chinese population with amyotrophic lateral sclerosis

文献详情

资源类型:
Pubmed体系:
机构: [1]Department of Neurology, Peking University Third Hospital, Beijing, China. [2]Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China. [3]Beijing Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Beijing, China, and. [4]Key Laboratory for Neuroscience, National Health Commission/Ministry of Education, Peking University, Beijing, China.
出处:
ISSN:

关键词: Amyotrophic lateral sclerosis contralateral co-movement test mirror movements Chinese version

摘要:
Mirror movements (MMs) are often overlooked in patients with amyotrophic lateral sclerosis (ALS). Although the contralateral co-movement (COMO) test can be used to evaluate MMs in patients with ALS, it lacks a systematic evaluation. The aim of this study was to validate the effectiveness of the Chinese version of the COMO test in a Chinese ALS population.We prospectively enrolled 173 patients with ALS as the disease group and 28 healthy individuals as controls. All participants were evaluated using the Chinese version of the COMO test. Univariate analysis and multiple linear regression were used to compare differences between groups. Subgroup analysis of the COMO scores was performed based on different disease characteristics.The COMO score in the ALS group was significantly greater (5.00% [1.67-10.00]) than that in the healthy control group (1.67% [0.00-3.33]). After adjusting for confounders, this difference remained significant. Multivariate linear analysis suggested that the upper motor neuron (UMN) score independently predicted the COMO score (P < 0.001). The COMO score was not affected by different onset regions or lateralizations. Propensity score matching revealed no significant difference in COMO scores between uninvolved limb segments and the corresponding limb segments in other patients. The Cronbach's α of the Chinese COMO test was 0.621.The Chinese COMO test can serve as a potential tool for assessing MMs in Chinese patients with ALS. The UMN score is a factor influencing the COMO score. The COMO test can provide objective evidence for ALS characteristics and the severity of UMN damage.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2024]版:
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 临床神经病学
第一作者:
第一作者机构: [1]Department of Neurology, Peking University Third Hospital, Beijing, China. [2]Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
通讯作者:
通讯机构: [1]Department of Neurology, Peking University Third Hospital, Beijing, China. [3]Beijing Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Beijing, China, and. [4]Key Laboratory for Neuroscience, National Health Commission/Ministry of Education, Peking University, Beijing, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16842 今日访问量:0 总访问量:902 更新日期:2025-03-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院